Does change in natriuretic peptide indicate clinically meaningful change in heart failure status in stable heart failure?

Back

HFA Premium Access

Does change in natriuretic peptide indicate clinically meaningful change in heart failure status in stable heart failure?

Session: ePosters in chronic heart failure - biomarkers (2)

Topic: Biomarkers

Speaker: Doctor G. Bruno (Dublin, IE)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Giulia Bruno

St Vincent's University Hospital, Dublin (Ireland)

0 follower

5 more presentations in this session

The association between the neutrophil-to-lymphocyte ratio and the risk of chronic heart failure in obese patients following myocardial infarction

Speaker: Doctor A. Kobets (Kharkiv, UA)

B-type natriuretic peptide predicts mortality in patients with acute ischemic stroke

Speaker: Professor K. Hong (Chuncheon, KR)

The role of CA125 as a congestion biomarker in ischemic heart failure

Speaker: Doctor M. Paralta De Figueiredo (Evora, PT)

CRP: a game-changer in predicting adverse cardiovascular events in hospitalized patients?

Speaker: Doctor R. Gonzalez Mayo (Ciudad de Mexico, MX) Miss M. Bejarano Vergara (MX)

NT-proBNP as a prognostic biomarker in acute de novo heart failure: insights from the COMFE registry

Speaker: Doctor O. Otero Garcia (Santiago de Compostela, ES)

Access the full session

ePosters in chronic heart failure - biomarkers (2)

Speakers: Doctor G. Bruno, Doctor A. Kobets, Professor K. Hong, Doctor M. Paralta De Figueiredo, Doctor R. Gonzalez Mayo...

Access

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources